Prevent Group B Strep(GBS)

Functionality & Mechanism

Developed by the Centers for Disease Control and Prevention (CDC) and endorsed by major professional bodies, this clinical decision support tool synthesizes complex GBS prevention guidelines into an interactive, point-of-care workflow. The interface captures patient- and scenario-specific data through a sequence of up to 12 questions. Based on these inputs, the system delivers customized, evidence-based management recommendations, including the necessity of intrapartum antimicrobial prophylaxis and optimal antibiotic regimens for penicillin-allergic patients.

Evidence & Research Context

• The app's design is detailed in associated research, which describes its development as a tool to improve the implementation of intricate national guidelines for GBS prevention.
• Its logic and recommendations are explicitly grounded in clinical protocols and Committee Opinions from the American College of Obstetricians and Gynecologists (ACOG).
• The platform translates multi-page guideline documents into a streamlined digital format to facilitate rapid decision-making in high-pressure clinical environments.
• Key functionalities, such as guidance on universal screening timing and antibiotic selection, directly align with evidence-based standards aimed at reducing neonatal GBS disease.

Intended Use & Scope

This application is intended for obstetric and pediatric clinicians, including physicians, nurse-midwives, and pediatricians, as a point-of-care reference tool. Its primary utility is providing rapid, standardized guidance on GBS prophylaxis. The tool is designed to augment, not replace, independent clinical judgment, and complex cases may warrant further consultation or adherence to local institutional protocols.